WASHINGTON, June 23 — The Food and Drug Administration today blocked e-cigarette maker Juul Labs Inc from selling its nicotine products in the United States, potentially dealing a fatal blow to the once high-flying San Francisco company.
Following a nearly two-year-long review of scientific and public health data submitted by the company, the FDA said the applications “lacked sufficient evidence” regarding the toxicological profile of the products to demonstrate that marketing them would be appropriate for the protection of public health.
Juul, along with other e-cigarette brands including British American Tobacco Plc’s Vuse and Imperial Brands Plc’s Blu, had to meet a September 2020 deadline to file applications to the FDA showing that its products provided a net benefit to public health.
The agency had to judge whether each product was effective in getting smokers to quit and, if so, whether the benefits to smokers outweighed the potential health damage to new e-cigarette users — including teenagers — who never smoked.
“We recognise these make up a significant part of the available products and many have played a disproportionate role in the rise in youth vaping,” FDA Commissioner Robert Califf said in a statement today.
Juul did not immediately respond to a Reuters request for comment.
Juul and other e-cigarette makers have been selling products in the United States for years without being officially authorised by the FDA, as regulators have repeatedly delayed deadlines for e-cigarette companies to comply with federal guidelines.
Teenage use of e-cigarettes surged with the rise in popularity of Juul in 2017 and 2018.
E-cigarette use among high school students grew from 11.7 per cent in 2017 to 27.5 per cent in 2019, before falling back to 11.3 per cent in 2021, according to a federal survey.
Researchers who conducted the survey for the US Centres for Disease Control and Prevention said the most recent youth e-cigarette data cannot be compared to earlier years because of changes in how the survey was conducted during the Covid-19 pandemic.
In 2020, the FDA banned all flavours except tobacco and menthol for cartridge-based e-cigarettes such as Juul. The company had pulled all other flavours including mint and mango in late 2019, following regulatory scrutiny and an outcry from anti-smoking advocates.
The Biden administration has been looking at other ways to help people quit smoking in an effort to cut down on preventable cancer deaths. It said this week it plans to propose a rule establishing a maximum nicotine level in cigarettes and other finished tobacco products to make them less addictive.
Altria Group Inc, which has a 35 per cent stake in Juul, closed down 9 per cent on Wednesday after the Wall Street Journal first reported, citing people familiar with the matter, the FDA was preparing to order Juul to take its e-cigarettes off the market. — Reuters
